LIZODAC 600 contains Linezolid 600 mg, a synthetic oxazolidinone antibiotic that inhibits bacterial protein synthesis, making it highly effective against resistant Gram-positive bacteria. It is particularly used for MRSA, VRE (Vancomycin-Resistant Enterococci), and pneumonia.
Highly Effective Against Drug-Resistant Bacteria – Targets MRSA, VRE, and Streptococcus pneumoniae.
Excellent Oral Bioavailability – Can be taken orally or intravenously with equal effectiveness.
Rapid Bacterial Clearance – Provides faster recovery and symptom relief.
Why Choose LIZODAC 600?
Highly Effective Against MRSA & VRE – A preferred choice for multi-drug resistant infections.
Superior Activity Against Pneumonia – Treats nosocomial and community-acquired pneumonia (CAP).
Strong Penetration into Tissues – Ensures effective bacterial eradication.
Oral & IV Equivalence – Allows easy transition from hospital to home treatment.
Lower Resistance Development – An alternative to vancomycin in resistant infections.
Indications
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Covers skin, soft tissue, and systemic infections.
Vancomycin-Resistant Enterococcus (VRE) Infections – Treats resistant urinary and systemic infections.
Community-Acquired Pneumonia (CAP) & Nosocomial Pneumonia (HAP) – Effective against Streptococcus pneumoniae & Staphylococcus aureus.
Skin & Soft Tissue Infections – Treats cellulitis, abscesses, and diabetic foot infections.
Complicated Urinary Tract Infections (UTIs) – Covers Gram-positive resistant uropathogens.
Bacteremia & Septicemia – Controls serious bloodstream infections caused by resistant bacteria.
Dosage & Administration
Recommended Dosage:
Standard Dose: 600 mg every 12 hours for 10-14 days, or as prescribed.
For Severe Infections: 600 mg every 12 hours for up to 28 days.
Administration:
Can be taken with or without food – Food does not affect absorption.
Swallow whole with water – Do not crush or chew.
Complete the full course to prevent antibiotic resistance.
Precautions & Warnings
Do Not Use in Patients with Known Linezolid Allergy – May cause severe hypersensitivity reactions.
Monitor Blood Counts in Long-Term Use – May cause thrombocytopenia or anemia.
Avoid in Patients Taking MAO Inhibitors – Risk of serotonin syndrome.
May Cause Mild Side Effects – Includes nausea, headache, diarrhea, or dizziness.
Use with Caution in Hypertensive Patients – May interact with tyramine-rich foods.
Not Recommended During Pregnancy & Lactation – Use only if benefits outweigh risks.
Seek medical attention for severe allergic reactions, vision changes, or persistent diarrhea.
LIZODAC 600 (Linezolid 600 mg) is a potent, broad-spectrum antibiotic designed to combat drug-resistant Gram-positive infections, including MRSA, VRE, and pneumonia. With excellent tissue penetration, strong antibacterial activity, and high oral bioavailability, LIZODAC 600 ensures superior infection control and faster recovery.
MRSA & VRE Coverage | High Oral Bioavailability | Strong Pneumonia Treatment
CHOOSE LIZODAC 600 FOR EFFECTIVE RESISTANT INFECTION MANAGEMENT!
Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.
For more such product information and similar product category Anti Bacterials
You can also contact us www.dakshpharma.com/contact-us
